Search tool

video cover — shows a doctor wearing blue gloves about to perform an autopsy

Drug-related deaths: why data matter to save lives

Drug use is a major cause of harm and premature deaths among European adults. Many drug-related deaths are a direct result of a drug overdose. But drugs also contribute to other kinds...

Infographic showing opioids notifications and seizures

Infographic: opioids notifications to the Early Warning System and seizures

This infographic coming from the publication New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning System presents some key statistics on...

Infographic showing benzodiazepines notifications and seizures

Infographic: benzodiazepines notifications to the Early Warning System and seizures

This infographic coming from the publication New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning System presents some key statistics on...

Infographic showing graphs on NPS notifications and seizures

Infographic: new psychoactive substances — notifications to the Early Warning System and seizures

This infographic coming from the publication New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning System presents some key statistics on...

Some key cannabis prevalance use data for young adults in Europe. Less than 20% have used cannabis in the last year. There are wide variations between countries, from 2% to over 20%. More men report using than women. Frequency of use varies widely.

Cannabis use in the last year in Europe – young adults (15-34)

This infographic, developed to accompany the miniguide Cannabis: health and social responses in Europe presents some key statistics on cannabis use among young people (15-34) in the EU-27, Norway and Turkey...

Cannabis users are the most likely to report using more than one drug other than their primary drug, followed by opioids and cocaine users.

Infographic: polydrug use among clients entering treatment by primary drug in the EU-27, Norway and Turkey, 2020

This infographic, developed to accompany the miniguide Polydrug use: health and social responses in Europe presents some key statistics on the polydrug use among clients entering treatment by in the EU-27, Norway...

Graphics showing notifications and seizures of synthetic cannabinoids

Infographic: synthetic cannabinoids notifications to the Early Warning System and seizures

This infographic coming from the publication New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning System presents some key statistics on...

Infographic showing graphics and data on synthetic cathinones notifications and seizures

Infographic: synthetic cathinones notifications to the Early Warning System and seizures

This infographic coming from the publication New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning System presents some key statistics on...

prevalence of last year amphetamines use among young people in Europe is low but there are wide geographical differences between countries, ranging from less than 1% to almost 5%

Infographic: amphetamines use in the last year in Europe – young adults (15-34)

This infographic, developed to accompany the miniguide Stimulants: health and social responses in Europe presents some key statistics on the use of amphetamines among young people (15-34) in the EU-27, Norway and...

Infograhics shows overview of statistics of clients entering treatment for cannabis use in Europe. Most are men, in stable accomodation and self-referred. There are a range of employment statuses. Most are in stable accomodation.

Infographic: clients entering treatment for cannabis in Europe

This infographic, developed to accompany the miniguide Cannabis: health and social responses in Europe presents some key statistics on clients entering treatment with cannabis as their primary drug in the EU-27, Norway...